PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-6.65%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.28B
AUM Growth
+$3.28B
(-20%)
Cap. Flow
-$697M
Cap. Flow
% of AUM
-21.29%
Top 10 Holdings %
Top 10 Hldgs %
43.2%
Holding
108
New
22
Increased
17
Reduced
27
Closed
31
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$142M |
| 2 |
NXP Semiconductors
NXPI
|
$77.5M |
| 3 |
Cigna
CI
|
$60.4M |
| 4 |
Novartis
NVS
|
$59.7M |
| 5 |
PTC Therapeutics
PTCT
|
$55.9M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$224M |
| 2 |
Humana
HUM
|
$149M |
| 3 |
ICU Medical
ICUI
|
$97.4M |
| 4 |
Sarepta Therapeutics
SRPT
|
$83.1M |
| 5 |
Alibaba
BABA
|
$82M |
Sector Composition
| 1 | Healthcare | 61.59% |
| 2 | Technology | 15.83% |
| 3 | Financials | 1.15% |
| 4 | Communication Services | 1.06% |
| 5 | Consumer Discretionary | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Exact Sciences
EXAS
$8.98B
| – | – | -418,329 | Closed | -$49.4M |
|
77
Fair Isaac
FICO
$36.5B
| – | – | -56,215 | Closed | -$17.7M |
|
|
78
Humana
HUM
$36.5B
| – | – | -562,177 | Closed | -$149M |
|
|
79
ICU Medical
ICUI
$3.15B
| – | – | -386,592 | Closed | -$97.4M |
|
80
Inogen
INGN
$216M
| – | – | -141,077 | Closed | -$9.42M |
|
81
McKesson
MCK
$85.4B
| – | – | 0 | – | – |
|
82
Madison Square Garden
MSGS
$4.75B
| – | – | -102,368 | Closed | -$28.7M |
|
83
Netflix
NFLX
$513B
| – | – | -105,639 | Closed | -$38.8M |
|
84
New York Times
NYT
$9.74B
| – | – | -1,301,486 | Closed | -$42.5M |
|
85
iShares S&P 100 ETF
OEF
$22B
| – | – | 0 | – | – |
|
86
Pacira BioSciences
PCRX
$1.2B
| – | – | -734,346 | Closed | -$31.9M |
|
87
Pfizer
PFE
$141B
| – | – | -1,632,685 | Closed | -$70.7M |
|
88
Progressive
PGR
$145B
| – | – | -653,485 | Closed | -$52.2M |
|
89
Qualcomm
QCOM
$173B
| – | – | 0 | – | – |
|
90
Invesco QQQ Trust
QQQ
$364B
| – | – | 0 | – | – |
|
91
Revvity
RVTY
$10.5B
| – | – | -213,370 | Closed | -$20.6M |
|
92
Sea Limited
SE
$110B
| – | – | -1,155,123 | Closed | -$38.4M |
|
|
93
Sarepta Therapeutics
SRPT
$1.78B
| – | – | -546,786 | Closed | -$83.1M |
|
94
Trip.com Group
TCOM
$48.2B
| – | – | -927,160 | Closed | -$34.2M |
|
95
Tenet Healthcare
THC
$16.3B
| – | – | -1,484,683 | Closed | -$30.7M |
|
96
Thermo Fisher Scientific
TMO
$186B
| – | – | -160,666 | Closed | -$47.2M |
|
97
UnitedHealth
UNH
$281B
| – | – | -61,321 | Closed | -$15M |
|
98
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
99
SPDR NYSE Technology ETF
XNTK
$1.25B
| – | – | 0 | – | – |
|
|
XYZ
100
Block, Inc.
XYZ
$48.5B
| – | – | -487,346 | Closed | -$35.3M |
|